http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 28 Aug 2026 16:14:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Entera+Bio+Ltd.++++++++++++++++++++++/26998037.html si-local-file:///var/storage/secattach/20260828/26998037.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Entera+Bio+Ltd.++++++++++++++++++++++/26998037.html Fri, 28 Aug 2026 16:14:00 -0400 ENTX O.38505617 http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Entera+Bio+Ltd.++++++++++++++++++++++/26998037.html si-local-file:///var/storage/secattach/20260828/26998037.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Entera+Bio+Ltd.++++++++++++++++++++++/26998037.html Fri, 28 Aug 2026 16:14:00 -0400 ENTX O.38505617 http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Press+Releases/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br/></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br/></b>November 9, 2026, Fireside Chat and 1x1 Meetings, Location: Boston, MA</p> <p><b>Evercore ISI 9th Annual Healthcare Conference<br/></b>November 30–December 2, http://www.streetinsider.com/Globe+Newswire/Correction%3A+Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26986345.html Thu, 27 Aug 2026 09:44:00 -0400 A.14185667 A.50214655 ENTX O.10869727 O.22066148 O.38505617 http://www.streetinsider.com/Press+Releases/Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26984957.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br /></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>2026 Leerink Partners Biopharma Summit<br /></b>September 23–25, 2026, in person, Location: Healdsburg, CA</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br /></b>November 9, 2026, Fireside http://www.streetinsider.com/Press+Releases/Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26984957.html Thu, 27 Aug 2026 08:00:00 -0400 ENTX http://www.streetinsider.com/Globe+Newswire/Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26984957.html <p>TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in the following upcoming fall investor conferences:</p> <p><b>2026 Cantor Global Healthcare Conference<br /></b>Fireside Chat: September 10, 2026 at 1:00 p.m. Eastern Time, Waldorf Astoria New York, 301 Park Avenue, New York, NY</p> <p><b>2026 Leerink Partners Biopharma Summit<br /></b>September 23–25, 2026, in person, Location: Healdsburg, CA</p> <p><b>Guggenheim Securities 3rd Annual Healthcare Innovation Conference<br /></b>November 9, 2026, Fireside http://www.streetinsider.com/Globe+Newswire/Entera+to+Participate+in+Upcoming+Fall+Investor+Conferences/26984957.html Thu, 27 Aug 2026 08:00:00 -0400 ENTX http://www.streetinsider.com/Equity+Offerings/Entera+Bio+Ltd.+%28ENTX%29+files+for+134.8M+share+offering+by+selling+stockholders/26961647.html <p>Entera Bio Ltd. (NASDAQ: ENTX) filed for up to 134,803,910 share offering by selling stockholders.</p> http://www.streetinsider.com/Equity+Offerings/Entera+Bio+Ltd.+%28ENTX%29+files+for+134.8M+share+offering+by+selling+stockholders/26961647.html Fri, 21 Aug 2026 16:19:28 -0400 ENTX http://www.streetinsider.com/Corporate+News/Entera+Bio+Ltd.+%28ENTX%29+files+for+134.8M+share+offering+by+selling+stockholders/26961647.html <p>Entera Bio Ltd. (NASDAQ: ENTX) filed for up to 134,803,910 share offering by selling stockholders.</p> http://www.streetinsider.com/Corporate+News/Entera+Bio+Ltd.+%28ENTX%29+files+for+134.8M+share+offering+by+selling+stockholders/26961647.html Fri, 21 Aug 2026 16:19:28 -0400 ENTX http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Entera+Bio+Ltd.++++++++++++++++++++++/26961607.html si-local-file:///var/storage/secattach/20260821/26961607.html http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Entera+Bio+Ltd.++++++++++++++++++++++/26961607.html Fri, 21 Aug 2026 16:16:00 -0400 ENTX O.38505617 http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Entera+Bio+Ltd.++++++++++++++++++++++/26961607.html si-local-file:///var/storage/secattach/20260821/26961607.html http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Entera+Bio+Ltd.++++++++++++++++++++++/26961607.html Fri, 21 Aug 2026 16:16:00 -0400 ENTX O.38505617 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Entera+Bio+Ltd.+++++++++++For%3A+Aug+18++Filed+by%3A+Camisasca+Riccardo+Paolo/26958485.html si-local-file:///var/storage/secattach/20260821/26958485.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Entera+Bio+Ltd.+++++++++++For%3A+Aug+18++Filed+by%3A+Camisasca+Riccardo+Paolo/26958485.html Fri, 21 Aug 2026 07:34:00 -0400 ENTX O.38505617 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Entera+Bio+Ltd.+++++++++++For%3A+Aug+18++Filed+by%3A+Camisasca+Riccardo+Paolo/26958485.html si-local-file:///var/storage/secattach/20260821/26958485.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Entera+Bio+Ltd.+++++++++++For%3A+Aug+18++Filed+by%3A+Camisasca+Riccardo+Paolo/26958485.html Fri, 21 Aug 2026 07:34:00 -0400 ENTX O.38505617 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Entera+Bio+Ltd.+++++++++++For%3A+Aug+18/26940830.html si-local-file:///var/storage/secattach/20260818/26940830.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Entera+Bio+Ltd.+++++++++++For%3A+Aug+18/26940830.html Tue, 18 Aug 2026 08:01:00 -0400 ENTX O.38505617 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Entera+Bio+Ltd.+++++++++++For%3A+Aug+18/26940830.html si-local-file:///var/storage/secattach/20260818/26940830.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Entera+Bio+Ltd.+++++++++++For%3A+Aug+18/26940830.html Tue, 18 Aug 2026 08:01:00 -0400 ENTX O.38505617 http://www.streetinsider.com/FDA/Entera+Bio+names+Riccardo+Camisasca+as+chief+medical+officer/26940744.html <p>Entera Bio Ltd. (NASDAQ: ENTX) has appointed Riccardo Paolo Camisasca, M.D., as chief medical officer, according to a company statement. The appointment comes ahead of a planned Phase 3 initiation for the company's lead drug candidate, EB613, an oral tablet treatment for osteoporosis.</p> <p>Dr. Camisasca brings more than 30 years of experience in clinical development, medical affairs, regulatory strategy, and R&D leadership. He most recently served as Global Head of Research & Development at Sumitomo Pharma Switzerland, where he oversaw the integration of R&D operations across Urovant, Enzyvant, Altavant, and Myovant. He has also held roles at Bial, Syneos Health, Takeda, http://www.streetinsider.com/FDA/Entera+Bio+names+Riccardo+Camisasca+as+chief+medical+officer/26940744.html Tue, 18 Aug 2026 08:00:26 -0400 ENTX